Lobe Labs

What Lobe Labs does

Lobe Labs is an early-stage, privately held company (publicly introduced February 24, 2026) building a developer platform for biological neural network computing, also referred to as biocomputing. The platform comprises three integrated components: a Hardware Abstraction Layer that provides a unified software interface across heterogeneous biocomputing substrates, an Experiment Framework offering modular tools for designing, running, and analyzing experiments on neural organoids with built-in safety monitoring and statistical validation, and Applications beginning with disease modeling for drug discovery. The company explicitly positions its Hardware Abstraction Layer as analogous to CUDA for GPUs, aiming to make working with living neurons accessible without specialized expertise, and leverages decades of neuroscience research for stimulation protocols and recording pipelines.

The target customer base spans three primary personas: medical and pharmaceutical researchers using neural organoids for drug discovery and disease research, AI/ML researchers seeking biological benchmarks and ground truth for understanding intelligence, and neuroscience researchers working with neural organoids who currently lack standardized tooling. Lobe Labs cites the human brain's roughly 20-watt power consumption and an estimated 10^6x energy-efficiency advantage over GPUs for equivalent tasks as the strategic rationale for biological computation, and references existing biocomputing efforts by FinalSpark and Cortical Labs as evidence of category viability.

The company is pre-revenue with no commercial product launch, no disclosed pricing, no named customers, and no funding rounds disclosed. Its go-to-market is community-led and product-led: open-source tools, a public blog, build-in-public methodology, and direct contact via [email protected]. The revenue model is not yet defined, with disease modeling services and a freemium/open-source posture indicated as the most likely eventual streams.

Name

Lobe Labs

Legal name

Lobe Labs

Website

https://lobelabs.io

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

1–10 employees

Short description

Lobe Labs is an early-stage, pre-revenue company building an open-source developer platform for biological neural network computing. It offers a hardware abstraction layer, experiment framework, and disease modeling applications targeting pharma researchers, AI/ML researchers, and neuroscientists working with neural organoids.

Ownership category

akta.pro rank

Product category

Biocomputing Software Platform

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industries

AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE), AI & Machine Learning (Foundations & Applied) (EDAMACAG)

Keywords

• Biological neural networks
• Biocomputing platform
• Neural organoid research
• Drug discovery modeling
• Hardware abstraction layer

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Disease Modeling Services: Long-term goal of testing drug efficacy in living neural tissue for faster, cheaper, and more biologically relevant drug screening. Revenue model not explicitly defined but implies professional services or licensing.
2. Open-Source Tools (Community): Building open-source tools for biocomputing. Currently no commercial product; focused on building in public and sharing research openly. Revenue model to be determined.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Lobe Labs is building an open-source development stack for biological neural networks, covering a unified hardware abstraction layer across biocomputing platforms, modular experiment tooling for designing and analyzing neural organoid experiments, and applications such as disease modeling for drug discovery and biological benchmarks for AI improvement. The offering is intended to make cellular intelligence accessible to researchers and developers without requiring specialized biocomputing expertise.

Product overview

Lobe Labs offers a unified biological intelligence platform consisting of three integrated components: the Hardware Abstraction Layer (a unified API providing cross-platform interoperability for biocomputing systems), the Experiment Framework (modular tools for designing, running, and analyzing neural experiments with built-in safety and reproducibility features), and Biological Neural Network Applications (targeting drug discovery and disease research using neural organoids as model systems). These products work together to make biological neural networks accessible for research and development.

Differentiator

Problem solved

Functional benefit

Products and services

• Hardware Abstraction Layer A unified software API that provides hardware abstraction for biological neural network platforms, handling low-level programming so that biocomputing platforms are interoperable without requiring specialized expertise. Targeted at researchers and developers working with neural organoids.
• Experiment Framework Modular tools for designing, running, and analyzing experiments on neurons, with built-in safety monitoring, statistical validation, and reproducibility tracking. Targeted at neuroscience and biomedical researchers running neural organoid experiments.
• Biological Neural Network Applications Practical applications of biological neural network computing, starting with disease modeling for drug discovery using neural organoids as model systems, and biological benchmarks of learning intended to improve AI systems. Targeted at pharmaceutical researchers and AI/ML researchers.

Quantifiable outcome

• 20W power consumption vs data center requirements - biological neural networks operate on roughly the power of a dim light bulb
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves2 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lobe Labs